Interleukin-15 biology and its therapeutic implications in cancer

This publication has 66 references indexed in Scilit:

• Simultaneous Blockade of Multiple Immune System Inhibitory Checkpoints Enhances Antitumor Activity Mediated by Interleukin-15 in a Murine Metastatic Colon Carcinoma Model
  Clinical Cancer Research, 2010
• Transient and persistent effects of IL-15 on lymphocyte homeostasis in nonhuman primates
  Blood, 2010
• Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
  New England Journal of Medicine, 2010
• Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
  New England Journal of Medicine, 2010
• IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease–associated inflammation and lymphomagenesis
  Journal of Clinical Investigation, 2010
• Interleukin-15 and Its Receptor Augment Dendritic Cell Vaccination against theneuOncogene through the Induction of Antibodies Partially Independent of CD4 Help
  Cancer Research, 2010
• Serum and muscle interleukin-15 levels decrease in aging mice: Correlation with declines in soluble interleukin-15 receptor alpha expression
  Experimental Gerontology, 2009
• Safety and immunologic effects of IL-15 administration in nonhuman primates
  Blood, 2009
• Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer
  Proceedings of the National Academy of Sciences, 2009
• IL-15 as a mediator of CD4 ⁺ help for CD8 ⁺ T cell longevity and avoidance of TRAIL-mediated apoptosis
  Proceedings of the National Academy of Sciences, 2008